Overcome Antigen Escape, Enhance Specificity, & Maximize Toxicity for Next-Generation Cell Therapies with Dual CARs, Combination Therapies, & Novel Armoring
The future of cell therapies is multi-faceted. At the Multi-Functional Cell Therapies Summit, we gather pioneers at the forefront of development to discuss the next generation of cell therapies, which boast safer, more efficacious targeting profiles.
Join Global Innovators to:
- Investigate and overcome relapse and resistance: leverage functional analysis, novel combination strategy, and dual-CAR approaches with Kite: A Gilead Company, In8bio and Leucid Bio Ltd.
- Harness the power of multiple cell types: from NK to gamma delta to TILs, using combination and hybrid modalities developed by Eureka Inc., NKarta Therapeutics and Iovance Biotherapeutics
- Implement logic and develop ‘decision-making’ cells: create robust, controllable activation in vivo with University of Pennsylvania and Ludwig Institute for Cancer Research Lausanne
Drug Developer Pricing - Conference + 2 Workshops - USD 2697.0
Drug Developer Pricing - Conference + 1 Workshop - USD 2348.0
Drug Developer Pricing - Conference Only - USD 1999.0
Academic Pricing - Conference + 2 Workshops - USD 2397.0
Academic Pricing - Conference + 1 Workshop - USD 2098.0
Academic Pricing - Conference Only - USD 1799.0
Standard Pricing - Conference + 2 Workshops - USD 3297.0
Standard Pricing - Conference + 1 Workshop - USD 2898.0
Standard Pricing - Conference Only - USD 2499.0
+44 (0)20 3141 8700